New combo therapy targets stubborn myeloma cells
NCT ID NCT05497804
First seen Feb 03, 2026 · Last updated May 21, 2026 · Updated 18 times
Summary
This study tests whether a combination of four chemotherapy drugs can improve outcomes for people with high-risk multiple myeloma. The drugs work by killing cancer cells or stopping them from growing. The main goal is to see if the treatment can make the cancer undetectable in tests and keep it that way for at least a year. About 17 adults with newly diagnosed high-risk myeloma are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mayo Clinic
Jacksonville, Florida, 32224-9980, United States
-
Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.